Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Launches
Pharma
The Oral GLP-1 Tracker: Wegovy pill numbers show its appeal
Fierce Pharma's weekly Oral GLP-1 Tracker monitors prescription trends for Novo Nordisk's Wegovy pill and Eli Lilly's Foundayo.
Angus Liu
,
Kevin Dunleavy
,
Fraiser Kansteiner
May 22, 2026 10:36am
Gilead says long-acting PrEP Yeztugo in line for $1B in '26 sales
May 8, 2026 11:30am
Pre-launch efforts linked to lasting drug awareness edge: report
May 8, 2026 4:52am
Novo's Wegovy pill debuts with $355M in Q1
May 6, 2026 11:21am
Verastem starts campaign to move cancer drugs into earlier lines
May 1, 2026 4:12am
UPDATED: Roche Q1 earnings see hits and misses across key products
Apr 24, 2026 1:55pm